Insider Transactions in Q4 2021 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
8,880
-4.16%
|
$0
$0.57 P/Share
|
|
Nov 05
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
8,880
-3.99%
|
$0
$0.89 P/Share
|
|
Oct 15
2021
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+12.5%
|
-
|
|
Oct 11
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
25,734
-10.37%
|
$0
$0.9 P/Share
|
|
Oct 08
2021
|
Edward Carr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,122
-6.78%
|
$29,122
$1.05 P/Share
|
|
Oct 08
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
22,763
-8.4%
|
$22,763
$1.05 P/Share
|
|
Oct 07
2021
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$0
$0.97 P/Share
|
|
Oct 05
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,447
-0.89%
|
$2,447
$1.05 P/Share
|